Gene and miRNA expression in giant cell arteritis—a concise systematic review of significantly modified studies
Authors:
- Tadeja KuretTKTadeja Kuret
- Blaž BurjaBBBlaž Burja
- Julia FeichtingerJFJulia Feichtinger
- Gerhard G. ThallingerGTGerhard G. Thallinger
- Mojca Frank-BertonceljMFMojca Frank-Bertoncelj
- Katja LakotaKLKatja Lakota
- Polona ŽigonPolona Žigon
- Snezna Sodin-SemrlSSSnezna Sodin-Semrl
- Saša ČučnikSČSaša Čučnik
- Matija TomšičMTMatija Tomšič
- Alojzija HočevarAHAlojzija Hočevar
- 1 August 2018
- journal article
- review article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (2) , 307-316
Abstract
Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.Keywords
Funding Information
- The Slovenian Research and Innovation Agency (P3-0314)
This publication has 47 references indexed in Scilit:
- Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritisAnnals of the Rheumatic Diseases, 2013
- Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal studyRheumatology, 2011
- Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritisArthritis & Rheumatism, 2011
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Th17 and Th1 T-Cell Responses in Giant Cell ArteritisCirculation, 2010
- Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic eventsAnnals of the Rheumatic Diseases, 2010
- MMP-12, a novel matrix metalloproteinase associated with giant cell arteritisRheumatology, 2009
- Gelatinase expression and proteolytic activity in giant-cell arteritisAnnals of the Rheumatic Diseases, 2007
- Perceptions of epigeneticsNature, 2007
- Tissue production of pro-inflammatory cytokines (IL-1 , TNF and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritisRheumatology, 2003